[Skip to Content]
[Skip to Content Landing]
Article
April 6, 1984

Caffeine as an Analgesic Adjuvant

Author Affiliations

From Rockland Research Institute, Orangeburg, NY (Drs Laska and Siegel); New York University, New York (Drs Laska, Siegel, and Sunshine); Bristol Myers Co, New York and Hillside, NJ (Dr Elvers and Mr Mueller), and Philadelphia (Dr Rubin).

JAMA. 1984;251(13):1711-1718. doi:10.1001/jama.1984.03340370043028
Abstract

Thirty clinical studies involving more than 10,000 patients conducted during the last 20 years have been analyzed to assess the value of caffeine as an analgesic adjuvant. Although most studies included patients with postpartum uterine cramping or episiotomy pain, some involved patients with pain from oral surgery or headache. In 21 of 26 studies, the relative potency estimates of an analgesic with caffeine to an analgesic without caffeine is greater than one. The pooled relative potency estimates in each of several major categories of combination analgesics are significantly greater than one. The overall pooled relative potency estimate is 1.41, with 95% confidence limits of 1.23 to 1.63; that is, to obtain the same amount of response from an analgesic without caffeine requires a dose that is approximately 40% greater than one with caffeine.

(JAMA 1984;251:1711-1718)

References
1.
 Over-the-counter drugs: Establishment of monograph for OTC internal analgesic, antipyretic and antirheumatic products .  Federal Register 1977;42( (July 8) ):35439-35487.
2.
 AMA Drug Evaluations , ed 5. Chicago, American Medical Association, 1983, pp 67-167.
3.
Beaver WT:  Mild analgesics: A review of their clinical pharmacology, II .  Am J Med Sci 1966;251:576-599.Crossref
4.
Beaver WT:  Aspirin and acetaminophen as constituents of analgesic combinations .  Arch Intern Med 1981;141:293-300.Crossref
5.
 When are drug combinations justified?  Drug Ther Bull 1980;18:37-40.
6.
 Non-narcotic analgesics .  Med Lett Drugs Ther 1966;8:7-8.
7.
Laska EM, Sunshine A, Zighelboim I, et al:  Effect of caffeine on acetaminophen analgesia .  Clin Pharmacol Ther 1983;33:498-509.Crossref
8.
Wallenstein SL:  Analgesic studies of aspirin in cancer patients , in Dale TLC (ed):  Proceedings of the Aspirin Symposium . London, The Aspirin Foundation, 1975, pp 5-10.
9.
Cooper A:  Comparative analgesic efficacies of aspirin and acetaminophen .  Arch Intern Med 1981;141:282-285.Crossref
10.
Finney DJ:  Statistical Methods in Biological Assay , ed 3. New York, Macmillan Publishing Co Inc, 1979, p 656.
11.
Laska E, Gormley M, Sunshine A, et al:  A bioassay computer program for analgesic clinical trials .  Clin Pharmacol Ther 1967;8:658-669.
12.
Commission on the Federal Drug Approval Process, Subcommittee on Natural Resources, Agriculture Research and Environment and the Subcommittee on Investigations and Oversight: Final Report. Government Printing Office, 1982.
13.
Laska EM, Sunshine A, Wanderling J, et al:  Quantitative differences in aspirin analgesia in three models of clinical pain .  J Clin Pharmacol 1982;22:531-542.Crossref
14.
Hollingsworth HL:  The influence of caffeine on mental and motor efficiency .  Arch Psychol 1912;22:1-5.Crossref
15.
Ritchie JM:  Central nervous system stimulants: II. The xanthines , in Goodman LS, Gilman A (eds):  The Pharmacological Basis of Therapeutics , ed 4. New York, Macmillan Publishing Co Inc, 1970, pp 367-378.
16.
Stephenson PE:  Physiologic and psychotropic effects of caffeine on man .  J Am Diet Assoc 1977;71:240-247.
17.
Goldstein AS, Kaizer S, Warren R:  Psychotropic effects of caffeine in man: II. Alertness, psychomotor coordination, and mood .  J Pharmacol Exp Ther 1965;150:146-151.
18.
Kozlowski T:  Effect of caffeine on coffee drinking .  Nature 1976;264:354-355.Crossref
19.
Goldstein A, Kaizer S, Whitby O:  Psychotropic effects of caffeine in man: III. Quantitative and qualitative differences associated with habituation to coffee .  Clin Pharmacol Ther 1969;10:489-497.
20.
White C, Lincoln CA, Pearce NW, et al:  Anxiety and muscle tension as consequences of caffeine withdrawal .  Science 1980;209:1547-1548.Crossref
21.
Moyer JH, Tashnek AV, Miller SI, et al:  The effect of theophylline with ethylenediamine (aminophylline) and caffeine on cerebral hemodynamics and cerebrospinal fluid pressure in patients with hypertensive headaches .  Am J Med Sci 1952;224:377-385.Crossref
22.
Driesbach RH, Pfeiffer CC:  Caffeine withdrawal headache .  J Lab Clin Med 1943;28:1212-1218.
23.
Advertising of Proprietary Medicines: Hearings Before the Subcommittee on Monopoly of the Select Committee on Small Business, US Senate, 92nd Cong (First Session on Effect of Promotion and Advertising of Over-The-Counter Drugs on Competition, Small Business, and the Health and Welfare of the Public, pt 1, May 25-26, June 15-17, 1971
24.
 Introduction: Analgesics , statement of W. H. Barr, pp 390-418, (June 16) , 1971, Washington, DC)
25.
Sechzer PH:  Post-spinal anesthesia headache treated with caffeine: II. Intracranial vascular distention, a key factor .  Curr Ther Res 1979;26:440-448.
26.
Williams MW:  Analgesic effect of the APC combination in rat .  Toxicol Appl Pharmacol 1959;1:447-453.Crossref
27.
Siegers CP:  Effects of caffeine on the absorption and analgesic efficacy of paracetamol in rats .  Pharmacology 1973;10:19-27.Crossref
28.
Seegers AJM, Jager LP, Zandberg P, et al:  The anti-inflammatory, analgesic and antipyretic activities of non-narcotic analgesic drug mixtures in rats .  Arch Int Pharmacodyn Ther 1981;251:237-254.
29.
Giertz H, Jurna I:  Effekte des Coffeins in Analgetics-gemischen .  Naturwissenschaften 1957; 44:445.Crossref
30.
Vinegar R, Truax JF, Selph JL, et al:  Potentiation of the anti-inflammatory and analgesic activity of aspirin by caffeine in the rat .  Proc Soc Exper Biol Med 1976;151:556-560.Crossref
31.
Fuchs HR, Giertz H:  Analgetisch Wirksame Arzneimittelgemisch .  Arzneimittelforsch 1960;10:526-530.
32.
Goodman LS, Gilman A:  The Pharmacological Basis of Therapeutics , ed 6. New York, Macmillan Publishing Co Inc, 1980, p 1751.
33.
Lasagna L:  The misleading advertisements of Bayer aspirin .  Fact , (May) -June 1964, pp 21-23.
34.
Fingl E:  Drug dosage, time of observation and duration of medication as factors in drug evaluation , in Tedeschi DH, Tedeschi RE (eds):  Importance of Fundamental Principles in Drug Evaluation . New York, Raven Press, 1968, pp 33-51.
35.
Currier RD, Westerberg MR:  Evaluation of a salicylamide compound in the treatment of headache .  Univ Mich Med Bull 1958;24:415-418.
36.
Marrs JW, Glas WW, Silvani J:  Report of an investigation of D-propoxyphene hydrochloride .  Am J Pharm 1959;131:271-276.
37.
Frey GH:  The role of placebo response in clinical headache evaluations .  Headache 1961; 1:31-38.Crossref
38.
Cass LJ, Frederik WS:  The augmentation of analgesic effect of aspirin with phenacetin and caffeine .  Curr Ther Res 1962;4:583-588.
39.
DeKornfeld TJ, Lasagna L, Frazier TM:  A comparative study of five proprietary analgesic compounds .  JAMA 1962;182:1315-1318.Crossref
40.
Bauer RO, Baptista A Jr, Gruber CM Jr:  Evaluation of propoxyphene napsylate compound in post partum uterine cramping .  J Med 1974;5:317-328.
41.
Moertel CG, Ahmann DL, Taylor WF, et al:  Relief of pain by oral medications: A controlled evaluation of analgesic combinations .  JAMA 1974;229:55-59.Crossref
42.
Winter L, Appleby F, Ciccone P, et al:  A double-blind, comparative evaluation of acetaminophen, caffeine, and the combination of acetaminophen and caffeine in outpatients with post-operative oral surgery pain .  Curr Ther Res 1983;33:115-122.
43.
Booy RH:  Pijnbestrijding Met-Eevnondize analgectica in de tand heelkunde .  Ned Tijdschr Tandheelkunde 1975;79:1-13.
44.
Wojicki J, Samochoviec L, Lawezynski L, et al:  A double-blind comparative evaluation of aspirin, paracetamol and paracetamol and caffeine (Finimal) for their analgesic effectiveness .  Arch Immunol Ther Exp 1977;25:175-179.
45.
Jain AK, McMahon FG, Ryan JR, et al:  Aspirin and caffeine in postpartum pain relief .  Clin Pharmacol Ther 1978;24:69-75.
46.
 Food and Drug Administration Advisory Review Panel on OTC Sedative, Tranquilizer, and Sleep-Aid Drug Products (40FR57292) .  Federal Register 1975;42( (Dec 8) ):35482-35485.
×